Integrated oncology solutions spanning early detection, targeted therapies, immunotherapy, AI-driven diagnostics, and global clinical research networks.
Our multidisciplinary framework combines genomic profiling, AI-assisted diagnostics, and adaptive treatment protocols to optimize outcomes.
Comprehensive next-generation sequencing and liquid biopsy analysis to identify actionable mutations, biomarkers, and resistance mechanisms early in the care pathway.
Deep learning models trained on multi-modal imaging and pathology datasets to enhance early detection accuracy, reduce false positives, and streamline biopsy workflows.
Dynamically adjusted treatment regimens based on real-time tumor response monitoring, pharmacogenomics, and predictive toxicity modeling.
From FDA-approved regimens to breakthrough investigational therapies, we deploy the full spectrum of modern oncology.
High-affinity kinase inhibitors and PARP modulators designed for specific oncogenic pathways across solid and hematologic malignancies.
Checkpoint inhibitors, bispecific T-cell engagers, and autologous CAR-T constructs engineered for refractory lymphomas and leukemias.
Proton beam therapy, MR-guided adaptive radiation, and stereotactic ablative radiotherapy for sub-millimeter precision targeting.
Nex-gen ADC platforms featuring novel linker chemistries and bystander-effect payloads for HER2-low and TROP2-expressing tumors.
Genetically modified viral vectors designed to selectively replicate within malignant cells while inducing robust systemic anti-tumor immunity.
Robotic-assisted oncologic resections, fluorescence-guided margin assessment, and nerve-sparing techniques for functional preservation.
A unified pipeline accelerating discovery to bedside through phase-appropriate clinical validation and real-world evidence generation.
Beyond clinical treatment, we provide continuous support across the survivorship continuum.
AI-powered mobile platform for real-time adverse event reporting and clinical team escalation.
Integrated mental health services, cognitive support, and behavioral therapy access.
Long-term follow-up protocols, rehabilitation networks, and peer mentorship initiatives.
Oncology treatment extends far beyond the infusion suite. Our patient ecosystem leverages digital health infrastructure, multidisciplinary care coordination, and behavioral science to reduce treatment burden, improve adherence, and enhance quality of life across every stage of the cancer journey.
Whether you're a clinical site, biotech innovator, health system, or patient advocate, discover how Aevum Zenth accelerates precision cancer care.